Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,210 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07449741RecruitingPhase 1
Early safety test of HXN6005 in healthy adults
This early-phase study tests an experimental drug called HXN6005 in healthy adults to see how safe it is and how the body handles it. It's looking for volunteers who are generally healthy and meet basic age and weight requirements.
Bayswater, VictoriaAges 18–55 - NCT07451002Recruiting
Study on Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer
This study looks at how well men with prostate cancer that has spread and is still hormone-sensitive stick to taking the drug apalutamide. It aims to understand real-world use and quality of life.
CaenAges 18 years+ - NCT07452198RecruitingPhase 3
Study of new drug for relapsed or hard-to-treat multiple myeloma
This trial tests a new medicine (GR1803) against a standard combination treatment for people whose multiple myeloma has come back or stopped responding to prior therapies. It aims to see if the new drug works better.
TianjinAges 18 years+ - NCT07454291RecruitingPhase 1
How taladegib works in healthy volunteers
This trial is for healthy volunteers to see how the study drug taladegib (ENV-101) interacts with other medicines in the body. It will help researchers understand how the drug is absorbed and processed, which is important for future studies in patients.
Brisbane, QueenslandAges 26–65 - NCT07454837RecruitingPhase 2/Phase 3
Switching to brelovitug for chronic hepatitis D patients on bulevirtide
This trial tests if switching from bulevirtide to brelovitug can help people with chronic hepatitis D (CHD). It is for adults who have been on bulevirtide for at least 6 months and still have detectable virus.
GrazAges 18 years+ - NCT07455578RecruitingPhase 1
Study of S-4321 for people with autoimmune or immune diseases
This trial tests a new medicine, S-4321, for people with various autoimmune conditions like rheumatoid arthritis, psoriasis, eczema, or lupus. It aims to see if the drug is safe and can help control the overactive immune system.
Charlestown, New South WalesAges 18–75 - NCT07457229RecruitingPhase 1
Study of Radiprodil in People With Liver Problems
This study tests a drug called radiprodil in people with different levels of liver problems. It helps doctors understand how the liver processes the drug, which could make future treatments safer.
DeSoto, TexasAges 18–75 - NCT07457736RecruitingEarly Phase 1
Testing a new imaging agent for the brain
This study tests a new radioactive dye called [18F]GATT-44 to see how well it can show a specific brain protein on a PET scan. It may help researchers better understand brain conditions in the future.
New Haven, ConnecticutAges 18–60 - NCT07458581Recruiting
Training program for elite women underwater rugby players
This study tests a training program for elite women underwater rugby players. It looks at how the program affects your game performance and hopefully reduces injury risk.
MedellínAges 18 years+ - NCT07461220RecruitingPhase 1/Phase 2
Testing IRL757 for apathy in Parkinson's disease
This trial tests a new drug called IRL757 to see if it is safe and helps with apathy (loss of motivation or interest) in people with Parkinson's disease. You need to have at least moderate apathy and a caregiver who can come to visits with you.
PlevenAges 50–90 - NCT07462780RecruitingPhase 1
Testing CMS-D017 in Healthy Volunteers
This trial tests a new investigational drug called CMS-D017 in healthy volunteers. Researchers will give single and multiple doses to see how the body processes it and if it's safe. You could help find an important new treatment.
BeijingAges 18–55 - NCT07463521RecruitingPhase 3
Study of rozanolixizumab for ocular myasthenia gravis
This study tests an investigational medication called rozanolixizumab for people who have ocular myasthenia gravis (MG), where weakness is only in the eye muscles. The medicine is given as an injection under the skin and may help improve symptoms like drooping eyelids or double vision.
Amherst, New YorkAges 18 years+ - NCT07463846RecruitingPhase 1/Phase 2
Study of ALN-2232 in people with obesity
This trial tests an investigational drug called ALN-2232 in people with obesity to see if it can help with weight management. You may be able to join if you have a BMI between 30 and 40 and do not have diabetes or take other weight-loss or diabetes medications.
Mount RoyalAges 18–65 - NCT07467447RecruitingPhase 2
Testing a weight-loss drug for people with obesity or overweight
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
Shenzhen, GuangdongAges 18–75 - NCT07470853RecruitingPhase 1
Study of HWK-016 for advanced ovarian or endometrial cancer
This trial tests a new drug called HWK-016, which is designed to target and deliver medicine directly to cancer cells that have a specific marker (MUC16). It is for people with advanced ovarian or endometrial cancer to see if it can shrink tumors or slow their growth.
Little Rock, ArkansasAges 18 years+ - NCT07470983RecruitingPhase 2
Study of HRS-1780 for Primary Aldosteronism
This trial tests a new drug called HRS-1780 for people with primary aldosteronism, a condition that causes high blood pressure. The goal is to see if the drug is safe and effective in lowering blood pressure and managing the condition.
Chongqing, Chongqing MunicipalityAges 18 years+ - NCT07471932RecruitingPhase 1
Testing a new skin medicine in healthy adults
This trial is testing a new study drug called LAD106 to see if it is safe in healthy adults. It helps researchers learn how the drug works in the body before moving on to patients with a specific condition.
LeidenAges 18–45 - NCT07472400Recruiting
Hip surgery recovery study for young adults with hip impingement
This study follows people before and after hip arthroscopy to treat femoroacetabular impingement (a condition where the hip bones pinch together). It measures strength, mobility, and daily function to see how recovery progresses over 6 months.
Sart Tilman, LiègeAges 18–40 - NCT07474987Recruiting
Virtual reality test for brain injury diagnosis
This study uses a virtual reality device that shines light into your eyes to check how your pupils react. It aims to help diagnose and track traumatic brain injury in soldiers.
Tel Litwinsky, Tel Aviv (Gosh Dan)Ages 18–67 - NCT07476144RecruitingPhase 1
Nordic Spirit pouch nicotine effects study in smokers
This study looks at how nicotine from Nordic Spirit pouches is absorbed and whether it might be habit-forming. It is for healthy adult smokers who want to test a tobacco-free nicotine pouch.
Knoxville, TennesseeAges 22–65 - NCT07476469Recruiting
Nerve stimulation for anhedonia and anxiety
This study tests whether a gentle nerve stimulation device (tVNS) placed on your ear can help reduce symptoms of anhedonia (loss of pleasure) and anxiety. You will also have brain scans (MRI) to see how the treatment affects your brain.
BonnAges 18–40 - NCT07476586RecruitingPhase 1
Study of GenSci161 safety in healthy adults
This trial tests a new medicine called GenSci161 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 45 who are willing to follow study rules and use birth control.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07477639RecruitingPhase 1/Phase 2
Testing TRX319 for worsening multiple sclerosis
This trial tests a new treatment called TRX319 for people with progressive multiple sclerosis (MS) that has been getting worse. The study wants to see if this treatment can help slow down disability progression.
Kansas City, KansasAges 18–65 - NCT07478744RecruitingPhase 2
Study for generalized anxiety disorder with SYT-510
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
LondonAges 18–55
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,210 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.